Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001086445 | SCV000761749 | likely benign | Charcot-Marie-Tooth disease axonal type 2L | 2025-01-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000761845 | SCV000892049 | uncertain significance | not provided | 2018-06-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000761845 | SCV001769605 | likely benign | not provided | 2019-07-12 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 31902012) |
Revvity Omics, |
RCV000761845 | SCV003811259 | uncertain significance | not provided | 2022-02-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004025592 | SCV004883645 | likely benign | Inborn genetic diseases | 2023-02-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV005000427 | SCV005622467 | likely benign | not specified | 2024-09-10 | criteria provided, single submitter | clinical testing |